Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 044466/0872 | |
| Pages: | 16 |
| | Recorded: | 12/21/2017 | | |
| Attorney Dkt #: | GP 29858-2 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
6
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/31/2020
|
Application #:
|
13060028
|
Filing Dt:
|
05/16/2011
|
|
Publication #:
|
|
Pub Dt:
|
08/25/2011
| | | | |
|
Title:
|
ENGINEERED SYNERGISTIC ONCOLYTIC VIRAL SYMBIOSIS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/02/2015
|
Application #:
|
13514837
|
Filing Dt:
|
06/08/2012
|
|
Publication #:
|
|
Pub Dt:
|
11/01/2012
| | | | |
|
Title:
|
ONCOLYTIC RHABDOVIRUS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
14651761
|
Filing Dt:
|
06/12/2015
|
|
Publication #:
|
|
Pub Dt:
|
10/29/2015
| | | | |
|
Title:
|
COMPOSITIONS AND METHODS FOR THE TREATMENT OF BRAIN CANCERS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/20/2018
|
Application #:
|
14696028
|
Filing Dt:
|
04/24/2015
|
|
Publication #:
|
|
Pub Dt:
|
10/01/2015
| | | | |
|
Title:
|
ONCOLYTIC RHABDOVIRUS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/30/2019
|
Application #:
|
14769035
|
Filing Dt:
|
08/19/2015
|
|
Publication #:
|
|
Pub Dt:
|
04/21/2016
| | | | |
|
Title:
|
VACCINE COMPOSITION
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/04/2018
|
Application #:
|
14898083
|
Filing Dt:
|
12/11/2015
|
|
Publication #:
|
|
Pub Dt:
|
05/12/2016
| | | | |
|
Title:
|
COMPOSITIONS AND METHODS FOR ENHANCING VIRUS REPLICATION
|
|
|
Assignee
|
|
|
|
|
| 1 FIRST CANADIAN PLACE |
| TORONTO, CANADA M5X 1B8 |
|
|
Correspondence name and address
|
| |
BORDEN LADNER GERVAIS LLP
|
| |
1200 WATERFRONT CENTRE, 200 BURRARD STR.
|
| |
VANCOUVER, V7X 1T2 CANADA
|
Search Results as of:
06/25/2024 07:50 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
| 
